Omega 3 Poly Unsaturated Fatty Acid (PUFA) is a type of fat which is essential for human health; but is not synthesized by the human body and hence, has to be consumed via food. The Omega 3 PUFA ingredients can be obtained from Animal and plant sources such as from fish oil, algae, krill, nut oil, etc. The Omega 3 PUFA, also known as Omega 3 fatty acids, play a significant role in maintaining the heart health, brain functioning, normal growth and in offsetting symptoms of various conditions like depression, diabetes, arthritis, etc. As a result of these benefits offered by Omega 3 PUFA, its market is expected to grow significantly in the forecast period.
The end-users of Omega 3 PUFA are the people with awareness of health benefits, the people who intake Omega 3 fatty acids for general nutrition, or for concerns related to chronic diseases.
New line of high concentrate DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) products are launched by DSM. Also, Incromega DHA is launched by Croda. These new technological introductions are ideal for cognitive health; the former one also provides cardiovascular support.
The increasing population in the emerging economies, the increasing concerns and awareness about health care, and the increasing demand for polyunsaturated fatty acids in functional food are contributing to the growth of the Omega 3 PUFA market. The growing range of health benefits provided by EHA and DHA omega 3 including significant reduction in chronic disease risks and increase in general nutrition is the central factor for the increasing demand and hence the growth of this market. However, the growth is restricted to some extend because of factors like high cost of production, high cost of raw materials like fish oil and lack of RDI (recommended dietary intake) standard.
The global Omega 3 PUFA market is segmented on the basis of type (EPA, DHA, ALA), source (Animal source – fish oil, algal oil, krill oil, others; and Plant source – chia seed, flex seed, hemp seed, others), application (food & beverages, dietary supplements, pharmaceuticals, infant formula, others), manufacturing technologies (fish oil processing, concentrating process, decontamination, other) and geography (North America, Europe, APAC, and Rest of World).
The North America region holds the highest market share in terms of both volume and value. This is because of the presence of key established players which keep on introducing new products in the market to attract new customers and retain the existing customers. The APAC region is also expected to experience major boost in the forecast period owing the huge population, awareness among people about the product and increase in the chronic diseases in the developing nations of the region. Europe is also estimated to experience a steady growth in the forecast period.
The market is expected to see new opportunities in the forecast period owing to the increase in research and development investments and activities by the key players. The ongoing product development and innovation to improve the effectiveness of Omega 3 is also expected to lead to new opportunities. The joint venture between Royal DSM and Evonik, named as Veramaris, is expected to bring about positive scope for innovations in the Omega 3 PUFA market.
Some of the major players in the market include Cargill, Incorporated, FMC Corporation, Croda International PLC, Pronova, BASF, Hain Celestial Group, Inc., Omega Protein Corporation, and Royal DSM, GC Rieber, Pharma Marine USA LLC.
- Market segments
- Market Drivers, Restraints and Opportunities
- Market Size & Forecast 2016 to 2022
- Supply & Demand Value Chain
- Market – Current Trends
- Competition & Major Companies
- Technology and R&D Status
- Porters Five Force Analysis
- Strategic and Critical Success Factor Analysis of Key Players
- North America
- US and Canada
- Latin America
- Mexico, Brazil, Argentina and Rest of Latin America
- Western Europe
- EU5 (Germany, France, Italy, Spain, U.K.)
- Nordic Countries (Denmark, Finland, Norway, and Sweden)
- Benelux (Belgium, The Netherlands, and Luxembourg)
- Rest of Western Europe
- Eastern Europe
- Rest of Eastern Europe
- Asia Pacific
- Australia and New Zealand
- Rest of Asia Pacific
- Middle East and Africa
- GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
- South Africa
- North Africa
- Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
- Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
- Consumer and Pricing Analysis
- Market dynamics of the industry
- Market Segmentation
- Estimated Market Sizing in terms of volume and value
- Recent trends in Market and impact
- Research Status and Technology Overview
- Extensive Industry Structure Coverage